{"id": "1374285963514548224", "creation": 1616490281.0, "user_id": "1304113315233370118", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "U.S. health body questions robustness of AstraZeneca's #COVID19 #vaccine trial data \n\nThe DSMB has \"expressed concern that #AstraZeneca may have included outdated info...which may have provided an incomplete view of the efficacy data,\" the NIAID said.\n\nhttps://t.co/xmgbEwBuFK", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#ASTRAZENECA"]}